loader image

Prof. André Spiegel appointed new Director of Institut Pasteur du Cambodge

Professor André Spiegel appointed as Director of Institut Pasteur du Cambodge Prof. André Spiegel was appointed Director of the Institut Pasteur du Cambodge. He succeeds Dr. Laurence Baril who held this position from 2019 to 2021. Doctor of medicine, Associate Professor of Val-de-Grâce in epidemiology and public health, André SPIEGEL held various responsibilities within the … Read more

290 mosquito species in Cambodia

290 mosquito species in Cambodia Between 2016 and 2020, the Medical and Veterinary Entomology unit of the Institut Pasteur du Cambodge collected over 230,000 mosquitoes. Based on this sampling effort, a checklist of 290 mosquito species in Cambodia is established.    This is the first attempt to list the Culicidae fauna of the country.   … Read more

Master of Infectiology

In order to ensure that outstanding students can follow the Master of Infectiology, the Institut Pasteur du Cambodge (IPC) will provide two scholarships to the best candidates.Please apply to the Master degree to be eligible for these competitive grants: https://bit.ly/3wgkCI6Only candidates accepted in the Master program will be able to apply for the scholarships. After … Read more

Newest Publication

The Institut Pasteur du Cambodge is pleased to share the publication of the paper below published in Science, the peer-reviewed academic journal of the American Association for the Advancement of Science (AAAS). This research on dengue is the result of a collaboration between the Immunology, Epidemiology and Public Health and Virology teams at Institut Pasteur du Cambodge

One year later: The first detection of Covid-19 in Cambodia

Exactly one year ago today, Institut Pasteur du Cambodge (IPC) identified the first confirmed case of COVID-19 in Cambodia. A long history of detecting and preventing emerging and endemic infectious diseases along with a rapid response to the global concern over “pneumonia of unknown origin” allowed IPC to be ready to test for SARS-CoV-2 in mid-January.